Modification Agreements in the Biotechnology Industry

121 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Debt Modification Agreement dated December 30, 2024
Modification Agreements
BIOXYTRAN, INC
Biotechnology
2025
Amendment to Debt Modification Agreement dated July 25, 2024
Modification Agreements
BIOXYTRAN, INC
Biotechnology
2025
Modification No. 21 to Undefinitized Project Agreement No. 1, dated February 6, 2024, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2024
Modification No. 20 to Undefinitized Project Agreement No. 1, dated December 1, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2024
Modification No. 19 to Undefinitized Project Agreement No. 1, dated September 19, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2024
Modification No. 18 to Undefinitized Project Agreement No. 1, dated May 25, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2023
Modification No. 17 to Undefinitized Project Agreement No. 1, dated February 6, 2023, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2023
Modification of Contract between the Company and the Department of Defense, United States of America, dated January 4, 2023
Modification Agreements
Immunome Inc.
Biotechnology
2023
Modification No. 03 to Base Agreement between the Company and Advanced Technology International, dated as of November 30, 2022
Modification Agreements
NOVAVAX INC
Biotechnology
2023
Modification Letter
Modification Agreements
Evelo Biosciences, Inc.
Biotechnology
NY
2022
Modification No
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 02 to Base Agreement between the Company and Advanced Technology International, dated as of August 2, 2022
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 06 to Project Agreement, dated as of July 12, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 04 to Project Agreement, dated as of July 12, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 03 to Project Agreement, dated as of May 21, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to Base Agreement, dated as of August 2, 2022, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 0
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 29, effective June 16, 2022, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 28, effective April 14, 2022, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification of Contract between the Company and the Department of Defense, United States of America, dated March 18, 2022 (portions of this exhibit (indicated by asterisks) have...
Modification Agreements
Immunome Inc.
Biotechnology
2022
Modification No. 01 to Base Agreement between Novavax, Inc. and Advanced Technology International, dated as of March 23, 2022
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 5 to Project Agreement, dated as of March 22, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 1 to Base Agreement, dated as of January 26, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 27, effective March 31, 2022, to the Solicitation/Contract/Order for Commercial Items (the CDC BioThrax Procurement Contract), effective December 8, 2016, from...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 13 to Undefinitized Project Agreement No. 01, dated February 1, 2022, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 12 to Undefinitized Project Agreement No. 01, dated December 20, 2021, between the Company and Advanced Technology International
Modification Agreements
NOVAVAX INC
Biotechnology
2022
Modification No. 32, effective November 1, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 31, effective October 20, 2021, to the BARDA ADM Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 8, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 4, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 3, effective
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 6, effective, November 1, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 5, effective, September 29, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 4, effective, July 13, 2021 to the ACAM2000 Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 1
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 26, effective November 1, 2021, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2022
Modification No. 25, effective September 29, 2021, to the CDC BioThrax Procurement Contract
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021
Modification No. 24, effective February 2, 2021, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and...
Modification Agreements
Emergent BioSolutions Inc.
Biotechnology
2021